Showing 2551-2560 of 9927 results for "".
DermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA for patients of dLiquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/series/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.New Tech Marries Data with Dermatology
https://practicaldermatology.com/topics/practice-management/new-tech-marries-data-with-dermatology/23574/Mindera Health seeks to cut costs and improve outcomes in psoriasis care.Frax Pro and CoolSculpting Elite Launch, Antibiotic Resistance in Rosacea, Thriving in Aesthetics Rolls Out
https://practicaldermatology.com/series/dermwire-tv/frax-pro-and-coolsculpting-elite-launch-antibiotic-resistance-in-rosacea-thriving-in-aesthetics-rolls-out/19896/The majority of rosacea patients have never heard of antibiotic resistance, a new survey reported by the National Rosacea Society finds. Candela’s Frax Pro system is now available, featuring Frax 1550 and the novel Frax 1940 applicators. Allergan Aesthetics, an AbbVie company, is launching CoolSculpRIP Clarisonic, Hello New Contenders
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/rip-clarisonic-hello-new-contenders/23354/CSF faculty share top picks for at-home beauty devices.Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.DermWireTV: AAD Virtual Data Highlights, Cynosure Consumer Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-virtual-data-highlights-cynosure-consumer-data/19818/The American Academy of Dermatology 2020 VMX Virtual Conference shines a light on fresh data from UCB, Leo Pharma, Lilly and Dermira, and Soliton. Cassiopea reports long-term data for Clascoterone. Zilxi from Menlo and Foamix approved for rosacea. Cynosure reports positive cosmetic consumer outlookIs it time to consider telemedicine at your dermatology practice?
https://practicaldermatology.com/topics/practice-management/is-it-time-to-consider-telemedicine-at-your-dermatology-practice/19779/Telemedicine is in high demand, now more than ever. This Ekwa Marketing video explores how well it fits with dermatology practices, and what it takes to implement it.Facing Challenges: Adapting Practice in the Face of COVID-19
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/facing-challenges-adapting-practice-in-the-face-of-covid-19/23266/CSF Faculty share experiences and tips for practicing in the “new normal.”Pigmentation Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/pigmentation-disorders/19730/Sunscreen may be the first, second, and third thing recommended for patients with pigmentation disorders, but what comes next? Joel Cohen, MD interviews Amit Pandya, MD to learn about treatment options and developments in the pipeline.